Job Watch

Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)

Funding Opportunity PAR-20-303 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in the U.S. Specifically, this FOA aims to stimulate scientific inquiry focused on innovative state and local level tobacco prevention and control policies. The long-term goal of this FOA is to reduce disparities in tobacco-related cancers, and in doing so, to promote health equity among all populations. Applicants submitting applications related to health economics are encouraged to consult NOT-OD-16-025 to ensure that the research projects align with NIH mission priorities in health economics research.

Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)

Funding Opportunity PAR-20-302 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in the U.S. Specifically, this FOA aims to stimulate scientific inquiry focused on innovative state and local level tobacco prevention and control policies. The long-term goal of this FOA is to reduce disparities in tobacco-related cancers, and in doing so, to promote health equity among all populations. Applicants submitting applications related to health economics are encouraged to consult NOT-OD-16-025 to ensure that the research projects align with NIH mission priorities in health economics research.

Notice of Special Interest: Advancing the Science of Geriatric Palliative Care

Notice NOT-AG-20-041 from the NIH Guide for Grants and Contracts

HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

Funding Opportunity PAR-21-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.

Almac Group Ltd: Biology Associate Scientist  

New Scientist - Bioinformatics - Wed, 2020-09-02 13:56
Competitive Salary: Almac Group Ltd: Working as part of the Almac Discovery Biology team, you will be responsible for the implementation and execution of biochemical and cellular assays Belfast
Categories: Job Watch

Heptares Therapeutics Limited: Discovery Safety Assessment/Pharmacology Scientific Leader

New Scientist - Bioinformatics - Wed, 2020-09-02 13:35
Competitive Salary: Heptares Therapeutics Limited: Sosei Heptares (the corporate brand of Sosei Group Corporation) is a research-focused biotechnology group... Welwyn Garden City, Hertfordshire (GB)
Categories: Job Watch

R&D/Scientist Recruiter - RPO - Virtual - Manpower Corporate - Milwaukee, WI

Indeed.com - Bioinformatics - Wed, 2020-09-02 13:27
Understand and educate client and program teams on the dynamics of the local market, labor and workforce management. Are you looking for a career with purpose?
From Manpower Corporate - Wed, 02 Sep 2020 17:27:08 GMT - View all Milwaukee, WI jobs
Categories: Job Watch

NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed)

Funding Opportunity RFA-AT-21-003 from the NIH Guide for Grants and Contracts. The NIH Blueprint for Neuroscience Research is a collaborative framework through which 14 NIH Institutes, Centers and Offices jointly support neuroscience related research, with the aim of accelerating discoveries and reducing the burden of nervous system disorders (for further information, see https://neuroscienceblueprint.nih.gov/). The goal of this FOA is to enhance our fundamental understanding of interoception with a specific focus on dissecting neural circuits connecting peripheral organs/tissues with the central nervous system via peripheral ganglia. For this FOA, interoception science includes studies of the processes by which an organism senses, interprets, integrates, and regulates signals originating from within itself. The FOA encourages projects that combine diverse expertise and use innovative approaches to delineate interoceptive mechanisms at the molecular, cellular, circuitry, functional, and/or behavioral levels. Outcomes of this research will lay a critical foundation for future translational and clinical research on interoception as well as its roles in nervous system disorders. Studies of interoceptive neural circuits exclusively within the central nervous system may consider seeking for BRAIN INITIATIVE funding opportunities.

Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)

Funding Opportunity RFA-ES-20-014 from the NIH Guide for Grants and Contracts. The National Institute of Environmental Health Sciences (NIEHS) is announcing the continuation of the Superfund Hazardous Substance Research and Training Program, referred to as Superfund Research Program (SRP) Centers. SRP Center grants will support problem-based, solution-oriented research Centers that consist of multiple, integrated projects representing both the biomedical and environmental science and engineering disciplines; as well as cores tasked with administrative (which includes research translation), data management and analysis, community engagement, research experience and training coordination, and research support functions. The scope of the SRP Centers is taken directly from the Superfund Amendments and Reauthorization Act of 1986, and includes: (1) advanced techniques for the detection, assessment, and evaluation of the effect on human health of hazardous substances; (2) methods to assess the risks to human health presented by hazardous substances; (3) methods and technologies to detect hazardous substances in the environment; and (4) basic biological, chemical, and physical methods to reduce the amount and toxicity of hazardous substances.

Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional)

Funding Opportunity RFA-DK-20-023 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support multidisciplinary research teams with complementary expertise in HIV and physiology, pathophysiology, pathobiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will provide comprehensive mechanistic analyses of the processes leading to the establishment and persistence of latent HIV reservoirs in anatomical sites relevant to the mission of the NIDDK, with the purpose of advancing progress toward developing a cure.

Wellcome Sanger Institute: Scientist Curator - Genetic Drivers of Cancer

New Scientist - Bioinformatics - Tue, 2020-09-01 03:05
£37,398 to £44,798: Wellcome Sanger Institute: We are seeking a motivated and experienced scientist in cancer molecular biology and genetics to lead the expansion and curation of the Cancer Gene... Hinxton, Cambridgeshire
Categories: Job Watch

Pages

Subscribe to Anil Jegga aggregator - Job Watch